• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI

    Transitioning from Clinical Production to Commercial Manufacturing

    Clinical Trial Technology

    Regenerative Medicine: Overcoming the supply chain challenges

    The Future of the Pharmaceutical Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness

    Amgen Selects Location For R&D Facility

    Arctoris Opens Oxford R&D Facility

    Almac Group, Exostar Collaborate on IRT Experience

    Northwest Biotherapeutics Expands Management Team
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Amgen Selects Location For R&D Facility

    Catalent Launches Clinical Trial Planning Service

    CatSci Expands Capabilities with Lab Expansion

    PCI Pharma Services Invests in Tredegar, UK Site

    Avantor Boosts Biopharmaceutical Innovation in China
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Smart Tags on Pills Set to Improve Supply Chain Security and Patient Adherence

    Schreiner MediPharm, PragmatIC Form Partnership for Smart Pharma Labels

    Stevanato Group Begins Construction on TEC

    CSafe Global Expands Packaging Portfolio

    CSafe Global Opens Service Centers in Switzerland and Sweden
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness

    Amgen Selects Location For R&D Facility

    Arctoris Opens Oxford R&D Facility

    Almac Group, Exostar Collaborate on IRT Experience

    Charles River Provides Access to Cosmic Antibody Library
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pelican BioThermal Achieves ISO Accreditation

    PhRMA Appoints Federal Advocacy SVP

    CureVac Granted Mfg. Authorization for GMP Production Suite

    Metrics Completes Japanese Regulatory Inspection

    Samsung Biologics Achieves ISO27001 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Ajinomoto Bio-Pharma Services

    Aphena Pharma Solutions, Inc.

    Vetter Pharma International GmbH

    Federal Equipment Company

    CCRM
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Vetter Pharma International GmbH

    Aphena Pharma Solutions, Inc.

    Jubilant HollisterStier Contract Manufacturing & Services

    Federal Equipment Company

    Flow Sciences, Inc.
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI

    The proven promise and huge potential of using AI and ML to accelerate drug discovery.

    Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI
    Related CONTENT
    • Vineti Opens New Regional HQ in Maryland
    • Serialization: A Lens Into the Digital Value Network
    • Speed, Quality and Cost
    • Cytel and Axio Research Merge
    • Artificial Intelligence and Machine Learning in Healthcare
    Lucas Glass, Gary Shorter, and Rajneesh Patil, IQVIA11.20.19
    Artificial intelligence (AI) and machine learning (ML) tools are transforming how clinical development occurs by delivering significant time and cost efficiencies while providing better and faster insights to inform decision-making. Advances in analytics technology coupled with the availability and integration of vast amounts of healthcare data have already helped automate processes and improve data quality across dozens of clinical development efforts.

    As these tools evolve, new opportunities will continue to emerge that drive further benefits to the clinical research landscape. Applications of AI and ML in healthcare are expected to grow to nearly $8 billion by 2022, up from $667.1 million in 2016, and almost half of global life science professionals say they are either using or interested in using AI in their research.1

    Despite this growth, the industry continues to struggle with what these technologies are and how they work. And there is uncertainty on how to surmount the challenges required to leverage AI and ML.

    When sponsors collaborate with partners that have the necessary technical and pharmaceutical expertise, they can achieve significant time and cost savings while reducing risks and improving the quality of their research. Here are five proven areas where AI and ML can directly impact operational efficiencies:

    1. Study design
    Poor study design has a catastrophic impact on the cost, efficiency and success potential of clinical trials. Leveraging vast healthcare data sets, AI, ML and natural language processing tools can be used to assess and select optimal primary and secondary endpoints during study design to ensure the most relevant protocols are defined for regulators, payers and patients. This helps to optimize the study design by informing ideal strategies for host countries and sites, enrollment models, patient recruitment and start-up plans.

    Better study design leads to more predictable results, reduced cycle time for protocol development, fewer protocol amendments and higher efficiencies throughout a study. It also results in improved recruitment rates and fewer non-enrolling sites. These improvements facilitate realistic and accurate planning and increase chances of success.

    2. Site identification and patient recruitment
    Identifying trial sites that have access to enough patients who meet inclusion/exclusion criteria is an ongoing challenge. As studies target more specific populations, recruiting goals become even harder to achieve, which drives costs up, increases timelines and raises the risk of failure. According to Tufts Center for the Study of Drug Development, nearly half of all sites miss enrollment targets.

    AI and ML can mitigate these risks by identifying and suggesting the sites with the highest recruitment potential and suggesting appropriate recruitment strategies. This involves mapping patient populations and proactively targeting sites with high predicted potential to deliver the most patients—before a single site is opened—and identifying the best avenues to recruit them. This means sponsors can open fewer sites, accelerate recruiting and reduce the risk of under-enrollment.

    3. Pharmacovigilance
    To ensure drug safety, massive amounts of structured and unstructured data must be integrated and reviewed. PV units that seek to harness the power of this data find that AI and ML technologies address many of the challenges they face by providing new levels of insight and predictive analytics. These tools can automate manual processing tasks and translate and digitize case safety reporting and adverse drug reaction documents. They can also monitor digital conversations on social media and other platforms to ensure that adverse events are promptly identified.

    Natural language processing, Optical character recognition, and deep neural networks are being used to analyze and format structured and unstructured data for faster and more efficient safety reviews.
    The insights derived from using AI for PV tasks lead to faster assessment of subject, site and study risks and overall study performance by domain experts. This allows project leads to increase efficiencies as well as patient safety.

    4. Clinical monitoring
    Tremendous manual effort is spent analyzing site risks and generating “action items” to mitigate those risks. AL and ML concepts can alleviate these pressures by assessing the risk environment and delivering predictive analytics to generate more effective clinical monitoring insights.

    Advanced analytics provide composite site rankings for holistic risk assessments, allowing for more specific identification of risks and removal of false positives. Using the composite evaluation of site risks across the study quickly shows high-risk sites, key risk indicators and site risk rank. Evaluations can also be used to proactively identify which sites are more likely to have recruitment and performance issues, or which patients are at higher risk for potential AEs. These insights facilitate faster action and avoid potential problems.

    5. Patient care
    Disease detection algorithms are now being designed to leverage medical information, such as symptoms and procedures that typically precede a diagnosis, to identify patients who are very likely to develop diseases. This allows for proactive care, as well as new recruiting insights for prodromal or early-stage disease studies and those that require treatment-naive patients.

    One area where this type of model is having a profound impact is Alzheimer’s disease research. Due to the exponential effects of a delayed AD diagnosis, much clinical research activity in AD is focused on the prodromal stage. Yet, traditional screenings for prodromal AD patients deliver only a 20 percent precision rate.

    AI and ML: Augmenting the Future of Clinical Development
    The clinical development landscape is changing quickly, and sponsors need to have the best insights to make the right decisions to increase predictability, reduce time to market and improve efficiencies. By using these methods in clinical development, we can introduce change to prove—and improve—how AI-derived insights can be applied to many aspects of development.
    These technologies aren’t going to replace human expertise. But they are going to accelerate the ability to analyze the data and take meaningful action in response to create a safer, more streamlined research environment. As the volume and complexity of clinical data continue to increase and more real-world evidence is introduced, AI applications have great potential value for the clinical trial process and the pharmaceutical drug discovery industry.

    Talent, Technology and Expertise
    These technologies hold huge promise for clinical development, but that promise can only be achieved when organizations have the tools, talent and partners to leverage these technologies in relevant ways. To achieve the full potential of AI and ML in clinical development, pharma companies need partners who can provide:
    • Deep pharmaceutical knowledge and domain expertise. This expertise should include in-depth understanding of healthcare data for insightful analyses, understanding of global regulatory environments, payer expectations, physician and patient behavior and therapeutic knowledge.
    • State-of-the-science AI and ML technologies. The solution should be capable of mining multiple data sets with speed and scale to identify high-level global and regional trends, as well as detailed physician- and patient-level insights while applying rigor through the GxP Software Development Life Cycle approach to produce top quality models.
    • Data analytics and machine learning experts. The customer team should include technical experts who are skilled in crafting machine learning algorithms relevant to the clinical development process.
    • Access to vast healthcare data sets. Machine learning algorithms are only as good as the data they can access. The most effective platforms will provide access to multiple global healthcare databases, including prescription data, EMRs, pharma sales data and patient and disease trend data that are updated regularly.
    • The ability to integrate these disparate data sets. Many healthcare data sets are unstructured or inconsistent in form and formatting, making them difficult to analyze. A good partner will have strategies in place to clean the data, so the algorithms can interpret results and translate them into actionable insights that drive better results.
    As the life sciences industry continues to evolve, more sophisticated analytics capabilities are required to advance the understanding of human health through better, more insightful decisions. Integrating human science with breakthroughs in data science and technology provides more relevancy and precision to decision-makers. It can transform how patients are diagnosed and treated, with minimal errors. It can help identify patients— faster and maybe even before they are patients.

    The proven promise and huge potential of using AI and ML to accelerate drug discovery while cutting costs and risks is a tremendous catalyst for innovation. By continuing to leverage data, intelligence, analytics and domain expertise, there is an enormous opportunity for the industry to fundamentally transform the clinical development landscape in ways that will greatly benefit patients, sponsors, payers and physicians alike. 

    References
    1. Source: Accenture, “Artificial Intelligence: Healthcare’s New Nervous System,” https://www.accenture.com/au-en/insight-artificial-intelligence-healthcare


    Lucas Glass is the Global Head of IQVIA’s Analytics Center of Excellence; responsible for researching, developing and operationalizing machine learning and data science solutions in the R&D business.

    Gary Shorter, Head of Artificial Intelligence, Research & Development Solutions, IQVIA. Gary Shorter holds an MSc and has served as global biostatistics lead for multiple compounds in clinical trials.

    Rajneesh Patil, Head of Process Design & Analytics, Centralized Monitoring Services, IQVIA. Rajneesh Patil’s expertise spans process design, project portfolio management, risk-based monitoring and advanced analytics for clinical trial applications.
    Related Searches
    • clinical development
    • quality
    • patients
    • Clinical Trial
    Suggested For You
    The Future of the Pharmaceutical Supply Chain The Future of the Pharmaceutical Supply Chain
    TraceLink Names Head of Intelligent Supply Network TraceLink Names Head of Intelligent Supply Network
    Genentech Selects Affimed Target in Immunotherapy Alliance Genentech Selects Affimed Target in Immunotherapy Alliance
    CPhI Annual Report 2019: Part 1 CPhI Annual Report 2019: Part 1
    The Role of Technology Within Regulatory Compliance in Bioanalysis The Role of Technology Within Regulatory Compliance in Bioanalysis
    Contract Pharma’s 20th Anniversary Series: CRO Perspective Contract Pharma’s 20th Anniversary Series: CRO Perspective
    Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI
    Will Artificial Intelligence Revolutionize Pharma? Will Artificial Intelligence Revolutionize Pharma?
     Lonza’s Ibex Solutions to Support Genmab’s Clinical Portfolio Lonza’s Ibex Solutions to Support Genmab’s Clinical Portfolio
    Probing the Limits of Pharma’s Future Probing the Limits of Pharma’s Future
    Contract Pharma’s 20th Anniversary Retrospective Contract Pharma’s 20th Anniversary Retrospective
    Nordic Nanovector, Isotope Technologies Enter Supply Pact Nordic Nanovector, Isotope Technologies Enter Supply Pact
    Covance Unveils New R&D Center in Shanghai Covance Unveils New R&D Center in Shanghai
    Leveraging Machine Learning and AI in Clinical Research Leveraging Machine Learning and AI in Clinical Research
    PRA Health Sciences Buys Out Joint Venture in Japan PRA Health Sciences Buys Out Joint Venture in Japan

    Related Features

    • Information Technology
      A Brave New World of Data Integrity

      A Brave New World of Data Integrity

      How modern CMOs are keeping up with stringent regulatory guidelines by embracing advanced laboratory information systems.
      Bob Voelkner, VP Sales and Marketing, LabVantage 06.13.19

    • Clinical Trials | Information Technology
      The New Horizon: Metaprise Analytics in Life Sciences

      The New Horizon: Metaprise Analytics in Life Sciences

      Going beyond enterprise analytics to metaprise analytics—patient-centric systems that create a data driven trial team.
      Michelle Longmire, MD, CEO and Founder, Medable 05.07.19

    • Information Technology
      The Manufacturing Revolution In Medicine

      The Manufacturing Revolution In Medicine

      Real-time data insights help both pharma companies and contract manufacturers meet regulatory requirements while ensuring high production standards.
      Petter Moree, OSIsoft, LLC 05.07.19


    • Information Technology
      Industry 4.0 in the Pharma Industry

      Industry 4.0 in the Pharma Industry

      Digitization is not a single-handed project.
      Dr. Christian Hanisch, Project Manager Industry 4.0 Pharma, Bosch Packaging Technology 03.06.19

    • Information Technology
      Digitization: Pharma 4.0

      Digitization: Pharma 4.0

      A look at how technology is impacting the pharma industry
      Fatih Kaya and Gerald Buerkle, Vetter Pharma 01.25.19

    • Information Technology
      FDA & Data Integrity

      FDA & Data Integrity

      FDA Publishes Final Guidance on Data Integrity
      Robert Marohn, Director of Quality Business Systems, Kite Pharmaceutical 01.25.19


    • Information Technology | Serialization | Supply Chain
      Serialization Compliance

      Serialization Compliance

      Automated data controls during packaging help improve compliance.
      Miguel Pitarch, Executive Director, Global Serialization, Bristol-Myers Squibb & the Bristol-Myers Squibb Serialization Team 11.13.18

    • Clinical Trial Materials | Information Technology
      Interactive Response Technology in Clinical Trial Supply

      Interactive Response Technology in Clinical Trial Supply

      Exploring the benefits of including IRT professionals earlier in trial planning
      Dave Holly, Senior Manager, IRT Development and Operations, Sharp Clinical Services 10.10.18

    • Drug Development | Information Technology | R&D
      CRO Industry Update: Big Data Drives Drug Development Efforts

      CRO Industry Update: Big Data Drives Drug Development Efforts

      With growth in virtual trials and RWE, the clinical development landscape may never look the same
      Kristin Brooks, Managing Editor 05.11.18


    • Information Technology | Serialization
      Stripping Serialization Back to Data Integrity

      Stripping Serialization Back to Data Integrity

      Why companies can’t afford to make compromises on quality
      Rachna Mohanka, Sr. Director, Global Solution Consulting, TraceLink 05.08.18

    • Information Technology | Regulatory Affairs
      Data Integrity: A Practical  and Risk-Based Approach

      Data Integrity: A Practical and Risk-Based Approach

      Ways an organization can form a culture and cost-effective means to meet the various challenges in sustaining data integrity.
      Robert Marohn, ClinLogic, LLC 09.06.17

    • Drug Delivery | Fill/Finish | Information Technology | Lyophilization | Serialization | Supply Chain | Vials
      Packaging Equipment Close-Up

      Packaging Equipment Close-Up

      To meet the wide-ranging needs of the marketplace, suppliers and contract packagers are looking to deliver flexible solutions.
      Kristin Brooks, Contract Pharma 03.09.16

    • Biologics, Proteins, Vaccines | Biosimilars | cGMP Manufacture | Clinical Trials | Drug Delivery | Drug Development | Drug Discovery | Facilities | Formulation Development | GMPs/GCPs | Information Technology | Preclinical Outsourcing | QA/QC | R&D | Regulatory Affairs
      Top 25 Pharma and Biopharma Report

      Top 25 Pharma and Biopharma Report

      (Based on 2014 Sales, in $U.S. Millions)
      07.20.15

    • Clinical Trials | Drug Development | Information Technology | R&D
      Driving Innovation Through Contracting

      Driving Innovation Through Contracting

      This article discusses the advantages to both biopharmaceutical companies and their vendors of moving outsourcing spend to a commercial model focused on the desired deliverable and not the level of effort required to achieve the deliverable.
      David Agrella, Bryan Haas, Pharm.D., Timothy King, Dr.P.H. and Scott Maisto , PPD 11.13.14

    • Drug Development | Information Technology | Supply Chain | Validation
      Agile Drug Development: Lessons from the Software Industry

      Agile Drug Development: Lessons from the Software Industry

      Why pharma needs to move from a “waterfall” to a “scrum” model
      Pedram Alaedini, Birnur Ozbas PhD, and Fahri Akdemir, Primapax and C1 Consulting 10.14.14

    Breaking News
    • Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    • Amgen Selects Location For R&D Facility
    • Arctoris Opens Oxford R&D Facility
    • Almac Group, Exostar Collaborate on IRT Experience
    • Northwest Biotherapeutics Expands Management Team
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI
    • Transitioning from Clinical Production to Commercial Manufacturing
    • Clinical Trial Technology
    • Regenerative Medicine: Overcoming the supply chain challenges
    • The Future of the Pharmaceutical Supply Chain
    • Challenges and Opportunities in Vaccines Drug Development
    • Managing Partnerships: Sponsors & CDMOs
    • Towards Sunset or a New Dawn?
    • Biopharma Over 20 Years
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs World's First Single-Use Duodenoscope
    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.